Investigation ¿ evaluation.Cook inc.Received a complaint from (b)(6) hospital in basingstoke, uk stating that an mwcer-35-14-14 (retracta detachable embolization coil) from lot 13965161 would not deploy in a patient.No damage was noted to the device prior to use, and the patient had normal anatomy with no significant angulation.The user rotated the device several times but the coil would not detach from the delivery wire.The device was removed and a new coil was placed to complete the procedure.A review of the complaint history, device history record, instructions for use (ifu), manufacturing instructions, quality control procedures, and specifications of the device, as well as a visual inspection and functional test of the returned product, were conducted during the investigation.The mwcer-35-14-14 was returned in a used and damaged condition.A visual examination confirmed the embolization coil was attached to the delivery wire, with evidence of dried biological matter.During table top testing, following the supplied ifu instructions, the coil was able to be removed from the delivery wire end coil, with approximately 9 counterclockwise turns.The proximal end of the embolization coil and the distal end of the delivery wire end coil were free of damage.Additionally, a document based investigation evaluation was performed.A device master record (dmr) review was performed, and device manufacturing instructions and quality control procedures associated with the complaint were identified.Cook has concluded that sufficient inspection activities are in place to identify this failure mode prior to distribution.The device history record (dhr) and relevant sub-assembly lots record no non-conformances.A database search revealed no other complaints have been reported for the device lot.The device is shipped with instruction for use (ifu) which provides the following information to the user related to the reported failure mode: intended use: ¿the retracta detachable embolization coil is intended for arterial and venous embolization in the peripheral vasculature.¿ warnings: ¿the retracta detachable embolization coil is not recommended for use with polyurethane catheters or catheters with sideports.If a catheter with sideports is used, the embolus may lodge in the sideport or pass inadvertently through it.Use of a polyurethane catheter may also result in lodging of the embolus within the catheter.¿ precautions: ¿prior to introduction of the embolization coil, flush the angiographic catheter with saline.¿ product recommendations: ¿the following catheters are recommended for use with retracta detachable embolization coils: hnb(r)4.0-35, hnb(r)5.0-35, hnb(r)5.0-38, scbr-5.0-38, scbr-4.0-38.¿ instructions for use: ¿6.Under fluoroscopic visualization, slowly advance the delivery wire until the entire length of the coil exits the distal end of the catheter.Ensure that the junction remains positioned just inside the catheter tip.Note: advancing the delivery wire slowly allows the junction to be seen more easily and reduces the risk of damaging it.Note: if significant resistance is encountered during coil advancement, do not continue advancing.Retract the delivery wire slightly, then gently re-advance it.If there is still significant resistance, withdraw the delivery wire from the catheter and try using a new coil with a shorter length." ¿8.If the coil position is correct, use the torque device to turn the delivery wire counterclockwise 8-10 times, until the coil detachment can be either felt or visualized under fluoroscopy.¿ how supplied: ¿upon removal from package, inspect the product to ensure no damage has occurred.¿ the review of the dhr, dmr, and returned device concluded the device was manufactured to specification and that there are no nonconforming devices in house or out in the field.Based on the information provided, the examination of returned product and the results of the investigation, the root cause conclusion for this complaint is component failure without a manufacturing or design deficiency.The appropriate internal personnel have been notified.Per the risk assessment, no further action is required.Cook will continue to monitor for similar complaints.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|